Cigna Stock – Too Cheap to Ignore – FAST Graphs


Research Articles

Cigna Stock – Too Cheap to Ignore On August 5, 2021, Cigna (CI) shares fell approximately 11%, which caused a lot of concern for investors. However, the news actually caused me confusion because Cigna reported that earnings beat by $0.27 and so did revenues. Consequently, I felt that the change in fundamentals that certain analysts […]

10 Equity REITs and Only 5 Are Buyable


Research Articles

Equity REITs This week’s subscriber request series Tuesday covers 10 popular equity REITs.  I will be covering 5 healthcare REITs, 3 specialized REITs 1 diversified REIT and 1 retail REIT.  All of these REITs but one have investment grade ratings of BBB- or better.  However, just like it is a market of stocks, it is […]

Pharma and Biotech Stocks On Sale


Research Articles

Introduction Pharma & Biotech Subscriber Request Series: 5 Biotechnology (biotech) and 2 Pharmaceutical (pharma) Companies on sale. Each Tuesday I cover stocks that have been requested from our channel’s YouTube subscribers. This week I covered pharmaceutical giant Merck (MRK) and the much smaller company in transition Teva Pharmaceutical (TEVA). In the biotechnology subindustry I covered […]

Owens & Minor Inc.: Irresistible Yield, Irresistible Valuation


Research Articles

Introduction Recently, I have had several requests to write an article about Owens & Minor Inc (OMI).  I had not looked at this company in a while, and boy oh, boy, was I surprised at what I found.  Owens & Minor is on the “Dividend Contender” list produced by David Fish. Owens & Minor has […]

Invest In Walgreens Or CVS – Speculate In Rite Aid


Research Articles

Introduction For many years now, investing in healthcare related stocks has presented me with a conundrum of sorts.  Demographic forces, primarily the graying of America (and the world for that matter), suggests powerful future growth potential and demand for healthcare related products and services.  On the other hand, healthcare and its costs have long been […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.